OpenAI acquires Orchestra Bio
This story was prepared automatically by software.

OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.
Source: https://openai.com/index/openai-to-acquire-orchestra-bio
Related articles





